Radifocus (Terumo) Versus Silverway (Asahi) to Deliver Catheters During Cardiac Catheterization
NCT ID: NCT05231889
Last Updated: 2022-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2022-02-15
2022-07-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Self-Centering Guide Catheter Feasibility Study
NCT02639494
Thoraflex™ Hybrid IDE Study
NCT02724072
Thoraflex Hybrid and Relay Extension Post-Approval Study
NCT05639400
Maximizing CRT Delivery by Using MultipolAr Coronary Sinus Lead FamiLy ACUITY® X4 - RALLY X4 Study
NCT02066467
Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent
NCT00967902
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
If this problem is encountered, interventional cardiologists will use a hydrophilic polymer-coated guide wire. Up to date there are several hydrophilic coated guide wires available. One of these is the Radifocus Guide Wire M (Terumo, Japan). Although it has better torque transmission than the spring wire, it still has low torque transmission due to a Nitinol core structure, is less supportive and can easily enter side branches because of the high lubricity and therefore might cause dissections or perforations.
In some cases, coronary angioplasty guide wires are needed to negotiate a highly tortuous artery, but they lack the support to advance the catheter.
Recently, the Silverway Guide Wire has been created (Asahi Intecc Co, LTD., Japan) to overcome the problems that a spring- and polymer wire have. Features that this new guide wire provide is hybrid coating and ACT ONE technology that connects the wire core and coil to ensure one to one torque transmission The investigators aim to compare both guide wires in deliverability, workability and complication rate.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Below the shoulder vascular anomaly
If the standard J-tip guidewire does not cross a vascular anomaly located below the shoulder
Radifocus guidewire
The Radifocus guidewire is a hydrophilic coated guidewire that is used when a standard J-tip guidewire does not cross a vascular anomaly
Above the shoulder vascular anomaly
If the standard J-tip guidewire does not cross a vascular anomaly located above the shoulder
Silverway guidewire
The Silverway guidewire is a newly developed guidewire to overcome the problems the Radifocus guidewire has
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Silverway guidewire
The Silverway guidewire is a newly developed guidewire to overcome the problems the Radifocus guidewire has
Radifocus guidewire
The Radifocus guidewire is a hydrophilic coated guidewire that is used when a standard J-tip guidewire does not cross a vascular anomaly
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being able to receive the per standard protocol Verapamil and Nitroglycerin administration via radial artery
* Not able to deliver a diagnostic or guiding catheter to the aortic root by means of the standard J tip wire
* No signs of early complication after initial attempt with the J tip wire such as dissection, perforation or hematoma
* Age ≥ 18 years
Exclusion Criteria
* Patients with known CREST syndrome or other forms of scleroderma
* Emergent indication for cardiac catheterization such as an acute coronary syndrome
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ziekenhuis Oost-Limburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Koen Ameloot
Medical doctor, Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Koen Ameloot, Dr.
Role: PRINCIPAL_INVESTIGATOR
Ziekenhuis Oost-Limburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Z-2021119
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.